2. Epigenetics Stem Cell/Wnt Protein Tyrosine Kinase/RTK JAK/STAT Signaling Apoptosis
  3. JAK STAT Apoptosis
  4. JAK2-IN-14

JAK2-IN-14 is an orally active JAK2 inhibitor with an IC50 of 2 nM. JAK2-IN-14 demonstrates 89.5-, 80.5-, and 51-fold selectivity over JAK1, JAK3, and TYK2, respectively. JAK2-IN-14 inhibits STAT5 signaling pathway. JAK2-IN-14 causes tumor cell cycle arrest and apoptosis. JAK2-IN-14 can used for the study of myeloproliferative neoplasms (MPNs).

For research use only. We do not sell to patients.

JAK2-IN-14

JAK2-IN-14 Chemical Structure

CAS No. : 3087335-24-5

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

JAK2-IN-14 Related Antibodies

Top Publications Citing Use of Products

View All JAK Isoform Specific Products:

View All Isoforms
JAK1 JAK2 JAK3 Tyk2 JAK

View All STAT Isoform Specific Products:

View All Isoforms
STAT3 STAT5 STAT6 STAT1

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

JAK2-IN-14 is an orally active JAK2 inhibitor with an IC50 of 2 nM. JAK2-IN-14 demonstrates 89.5-, 80.5-, and 51-fold selectivity over JAK1, JAK3, and TYK2, respectively. JAK2-IN-14 inhibits STAT5 signaling pathway. JAK2-IN-14 causes tumor cell cycle arrest and apoptosis. JAK2-IN-14 can used for the study of myeloproliferative neoplasms (MPNs)[1].

IC50 & Target[1]

JAK2

2 nM (IC50)

JAK1

179 nM (IC50)

JAK3

161 nM (IC50)

Tyk2

102 nM (IC50)

STAT5

 

In Vitro

JAK2-IN-14 (Compound 15au) (0.01-5 μM, 24 h) significantly induces cell cycle arrest at the G2/M phase and cell apoptosis in a dose-dependent manner in BaF3-JAK2V617F and HEL cells[1].
JAK2-IN-14 (0.05-1 μM, 2 h) effectively inhibits the phosphorylation of JAK2 and its downstream signaling molecule STAT5 in BaF3-JAK2V617F and HEL cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

JAK2-IN-14 Related Antibodies

Cell Cycle Analysis[1]

Cell Line: BaF3-JAK2V617F and HEL cells
Concentration: 10, 50, 100, 500 and 1000 nM
Incubation Time: 24 h
Result: Blocked the progression of tumor cells at the G2/M phase, leading to a decrease in the proportions of cells in the G1/G0 and G2 phases.

Western Blot Analysis[1]

Cell Line: BaF3-JAK2V617F and HEL cells
Concentration: 10, 50, 100, 500 and 1000 nM
Incubation Time: 2 h
Result: Reduced p-JAK2 and p-STAT5 levels concentration-dependently.
Parmacokinetics[1]
Species Dose Route Indicator value
Mice 5 mg/kg p.o. Cmax 2101.0 ng/mL
Mice 5 mg/kg p.o. Tmax 1.0 h
Mice 5 mg/kg p.o. T1/2 7.8 h
Mice 5 mg/kg p.o. CL/F 1.0 L/h/kg
Mice 5 mg/kg p.o. AUC0-t 5069.7 ng·h/mL
In Vivo

JAK2-IN-14 (Compound 15au) (7.5-40 mg/kg, p.o., once daily for 13-28 days) significant inhibits tumor growth in BaF3-JAK2V617F and HEL cells xenograft mice models[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BaF3-JAK2V617F allogeneic transplantation model established in BALB/c-nude mice[1]
Dosage: 7.5, 15 and 30 mg/kg
Administration: Oral administration (p.o.), once daily for 13 days
Result: Demonstrated significant therapeutic efficacy, reducing spleen weight by 24.1%, 26.4%, and 40.5% at doses of 7.5, 15, and 30 mg/kg, respectively
Animal Model: HEL cells xenograft model was established in 6-week-old male BALB/c nude mice[1]
Dosage: 20 and 40 mg/kg
Administration: Oral administration (p.o.), once daily for 28 days
Result: Significantly inhibited subcutaneous tumor growth.
did not induce observable body weight loss during the experimental period.
Molecular Weight

459.59

Formula

C26H33N7O
CAS No.
SMILES

CC1=CN=C(NC2=CC=C(N3CCN(CC4CC4)CC3)C5=C2)N=C1C6=CN(CCCCO5)N=C6
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

JAK2-IN-14 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

JAK2-IN-143087335-24-5JAKSTATApoptosisJanus kinasePharmacokinetic propertiesmacrocyclizationkinase selectivityBaF3-JAK2V617FHEL cellsInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
JAK2-IN-14
Cat. No.:
HY-175684
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.